The New Zealand Financial Markets Authority issued an infringement notice to Pharmazen Limited for failing to file audited financial statements for the year ended 31 December 2024 by the 30 April 2025 deadline under section 461H of the Financial Markets Conduct Act 2013, requiring payment of a NZD 7,500 infringement fee. Pharmazen, an FMC reporting entity, was also late filing financial statements in 2024 and 2023 and told the FMA the latest delay was driven by ongoing negotiations with its bank affecting the entity’s going concern assessment. Pharmazen has indicated it intends to publish its financial statements on 6 June 2025, and has 28 days to pay the infringement fee or respond to the notice.
New Zealand Financial Markets Authority 2025-05-30
New Zealand Financial Markets Authority issues infringement notice to Pharmazen Limited for late audited financial statements and NZD 7,500 fee
The New Zealand Financial Markets Authority issued an infringement notice to Pharmazen Limited for failing to file audited financial statements by the 30 April 2025 deadline, imposing a NZD 7,500 fee. Pharmazen, previously late in 2024 and 2023, cited ongoing bank negotiations as the cause and plans to publish the statements on 6 June 2025.